These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14127568)

  • 1. STABILIZATION OF PERTUSSIS VACCINE IN THE PRESENCE OF BENZETHONIUM CHLORIDE.
    OLSON BH; ELDERING G; GRAHAM B
    J Bacteriol; 1964 Mar; 87(3):543-6. PubMed ID: 14127568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RELATIVE STABILITY OF PERTUSSIS VACCINE PRESERVED WITH MERTHIOLATE, BENZETHONIUM CHLORIDE, OR THE PARABENS.
    GARDNER RA; PITTMAN M
    Appl Microbiol; 1965 Jul; 13(4):564-9. PubMed ID: 14339263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of benzethonium chloride on the antigens of pertussis vaccine.
    Wetterlow LH; Edsall G
    Int Arch Allergy Appl Immunol; 1970; 37(2):143-53. PubMed ID: 4189001
    [No Abstract]   [Full Text] [Related]  

  • 4. STUDIES OF PRESERVATIVES OF POLIOMYELITIS (SALK) VACCINE. I. BENZETHONIUM CHLORIDE.
    PIVNICK H; TRACY JM; GLASS DG
    J Pharm Sci; 1963 Sep; 52():883-8. PubMed ID: 14061050
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative stabilities of glutaraldehyde & heat inactivated pertussis vaccine components of adsorbed DPT vaccine with different preservatives.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Indian J Med Res; 1992 Jan; 95():8-11. PubMed ID: 1577522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THE ACTIVATION OF YEAST URIDINEDIPHOSPHOGALACTOSE-4-EPIMERASE BY SPERMINE AND OTHER CATIONS.
    DARROW RA; CREVELING CR
    J Biol Chem; 1964 Jan; 239():362-3. PubMed ID: 14114867
    [No Abstract]   [Full Text] [Related]  

  • 7. Bordetella pertussis culture having only species factor 1.
    Eldering G; Holwerda J; Baker J
    J Bacteriol; 1966 May; 91(5):1759-62. PubMed ID: 4287072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective proteolytic enzyme inhibitory action of benzethonium chloride.
    BECK IT; PINTER E; McKENNA RD; GRIFF H
    Can J Biochem Physiol; 1960 Jan; 38():25-32. PubMed ID: 13798039
    [No Abstract]   [Full Text] [Related]  

  • 9. ADDITIONAL uses of methylbenzethonium chloride.
    J Am Med Assoc; 1956 Jun; 161(5):459. PubMed ID: 13318944
    [No Abstract]   [Full Text] [Related]  

  • 10. THE DISSOCIATION OF HEMOGLOBIN BY INORGANIC SALTS.
    KIRSHNER AG; TANFORD C
    Biochemistry; 1964 Mar; 3():291-6. PubMed ID: 14155090
    [No Abstract]   [Full Text] [Related]  

  • 11. FACTORS INVOLVED IN THE STABILITY OF PERTUSSIS COMPONENT IN QUADRUPLE DPT-POLIO VACCINE.
    PONTECORVO M
    Riv Ist Sieroter Ital; 1964; 39():464-9. PubMed ID: 14259054
    [No Abstract]   [Full Text] [Related]  

  • 12. THE URINARY EXCRETION OF INORGANIC SALTS.
    ELLIOT JS
    Invest Urol; 1964 May; 1():582-6. PubMed ID: 14142902
    [No Abstract]   [Full Text] [Related]  

  • 13. The efficacy of diaparene chloride on the sterility of wet surgical linen.
    BAKER EJ; MADDEN JL
    Am J Surg; 1955 Sep; 90(3):437-9. PubMed ID: 13238704
    [No Abstract]   [Full Text] [Related]  

  • 14. Bactericidal activity of topical antiseptics and their gargles against Bordetella pertussis.
    Suzuki T; Kataoka H; Ida T; Kamachi K; Mikuniya T
    J Infect Chemother; 2012 Apr; 18(2):272-5. PubMed ID: 21968967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylbenzethonium chloride in the care of skin of infants and children.
    LIPSCHUTZ A; FISCHER CC
    AMA Am J Dis Child; 1955 May; 89(5):596-8. PubMed ID: 14360741
    [No Abstract]   [Full Text] [Related]  

  • 16. Ammonia dermatitis; treatment with diaparene chloride ointment.
    NIEDELMAN ML; BLEIER A
    J Pediatr; 1950 Nov; 37(5):762-4. PubMed ID: 14784932
    [No Abstract]   [Full Text] [Related]  

  • 17. Pearl Kendrick, Grace Eldering, and the pertussis vaccine.
    Shapiro-Shapin CG
    Emerg Infect Dis; 2010 Aug; 16(8):1273-8. PubMed ID: 20678322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-Mediated and Humoral Immune Responses to Bordetella pertussis Inactivated Whole-Cells Encapsulated Alginate Microspheres as a New Vaccine Candidate.
    Dounighi NM; Shahcheraghi F; Razzaghi-Abyaneh M; Nofeli M; Zolfagharian H
    Curr Pharm Biotechnol; 2017; 18(7):585-593. PubMed ID: 28814229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Storage at -3 degrees C for 24 h alters the immunogenicity of pertussis vaccines.
    Boros CA; Hanlon M; Gold MS; Roberton DM
    Vaccine; 2001 May; 19(25-26):3537-42. PubMed ID: 11348721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.